MODELE ODDZIAŁYWAŃ LIGANDÓW ARYLOPIPERAZYNYLOWYCH  Z RECEPTORAMI SEROTONINOWYMI 5-HT1A, 5-HT2A I 5-HT7

Anna Bielenica; Jerzy Kossakowski

doi:10.56782/pps.67

Published : 2010-03-23

Vol. 8 No. 2 (2010)

BINDING MODES OF LONG-CHAIN ARYLPIPERAZINES TO 5-HT1A, 5-HT2A AND 5-HT7 RECEPTORS

Anna Bielenica

Jerzy Kossakowski

DOI: https://doi.org/10.56782/pps.67

Abstract

The objective of this article is a presentation of selected docking models of long-chain arylpiperazines to 5-HT_1A, 5-HT_2Aand 5-HT₇ receptors. The most important types of interactions stabilizing the ligand-receptor complex were described. Several hypotheses proposed on the basis of homological modeling were discussed. In order to determine conformations of known alkyl- and alkoxypiperazinyl ligands, structural data from Cambridge Structural Database were analyzed.

Keywords:

docking, LCAPs, 5-HT1A receptor, 5-HT2A receptor and 5-HT7 receptor

Similar Articles

Martyna Z. Wróbel, Monika Marciniak, 5-HT1A RECEPTOR LIGANDS AS POTENTIAL ANTIDEPRESSANTS , Prospects in Pharmaceutical Sciences: Vol. 13 No. 5 (2015)
Agnieszka Sienicka, Krzysztof Kubasik, Agata Pisula, The glucagon-like peptide-1 analogues therapy in the non-diabetic patients , Prospects in Pharmaceutical Sciences: Vol. 21 No. 1 (2023)
Anna Bielenica, Jerzy Kossakowski, COMPUTATIONAL METHODS IN DETERMINATION OF PHARMACOPHORE MODELS OF 5-HT1A, 5-HT2A AND 5-HT7 RECEPTORS. , Prospects in Pharmaceutical Sciences: Vol. 8 No. 1 (2010)
Michał Dacka, Mateusz Sobczyk , Paulina Dąbrowska , Kamila Giżewska , Michał Żuber , Role of calcitonin gene-related peptide (CGRP) receptor antagonist in acute and preventive treatment of migraine , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Adam Piasecki, Magdalena Sitnik, Jakub Olszewski, Maciej Bara, Katarzyna Herjan, Piotr Armański, The changing landscape of mineralocorticoid receptor antagonists – finerenone in cardiovascular and renal health , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
Iwona Lewandowska Lewandowska, Monika Zielińska-Pisklak, Łukasz Szeleszczuk, Dariusz Maciej Pisklak, Marcin Sobczak, PULMONARY HYPERTENSION — PATHOPHYSIOLOGY AND DRUGS USED IN THERAPY , Prospects in Pharmaceutical Sciences: Vol. 18 No. 2 (2020)
Alicja Stępień, Paweł Stępień, Julia Kornatowska, Dexmedetomidine as an additive to local anesthesia in dentistry , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
Małgorzata Krzyżanowska, Katarzyna Kozon, Jakub Olszewski, Andrzej Patyra, Efficacy of satralizumab therapy in the treatment of NMOSD , Prospects in Pharmaceutical Sciences: Vol. 21 No. 3 (2023)
Anna Król, THE ROLE OF IMMUNE CELLS IN THE PATHOGENESIS OF GRAVES' ORBITOPATHY , Prospects in Pharmaceutical Sciences: Vol. 17 No. 3 (2019)
Maciej Bara, Jakub Starownik, Jakub Szydło, Patryk Gryszkiewicz, Jakub Nieznański, Dapagliflozin - new solution in chronic kidney disease treatment , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)

1 2 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Bielenica, A., & Kossakowski, J. (2010). BINDING MODES OF LONG-CHAIN ARYLPIPERAZINES TO 5-HT1A, 5-HT2A AND 5-HT7 RECEPTORS. Prospects in Pharmaceutical Sciences, 8(2), 13–21. https://doi.org/10.56782/pps.67

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

Sylte I., Bronowska A., Dahl S.G., Eur. J. Pharmacol. 2001, 416, 33

Kapetanovic I.M.,Chem. Biol. Interact. 2008, 171, 165 DOI: https://doi.org/10.1016/j.cbi.2006.12.006

Ishiguro M., ChemBioChem 2004, 5, 1210 DOI: https://doi.org/10.1002/cbic.200400068

Pardo L., Deupi X., Dölker N., Lopez-Rodriguez M.L., Campillo M., ChemBioChem 2007, 8, 19 DOI: https://doi.org/10.1002/cbic.200600429

Silverman R.B., Chemia organiczna w projektowaniu leków, WNT, Warszawa, 2007

Giacovazzo C., Fundaments of Crystallography, Oxford University Press, USA, 2002

Allen F. H., Acta Cryst., 2002, B58, 380 DOI: https://doi.org/10.1107/S0108768102003890

The Cambridge Structural Dabase, 2007, 5, 59

Siracusa M.A., Salerno L., Modica M.N., Pittala V., Romeo G., Amato M.E., Nowak M., Bojarski A.J., Mereghetti I., Cagnotto A., Mennini T., J. Med. Chem., 2008, 51, 4529 DOI: https://doi.org/10.1021/jm800176x

Paluchowska M.H., Bojarski A.J., Charakchieva-Minol S., Wesołowska A., Eur. J. Med. Chem., 2002, 37, 273 DOI: https://doi.org/10.1016/S0223-5234(01)01312-5

Nichols D. E., Nichols Ch.D., Chem. Rev. 2008, 108, 1614 DOI: https://doi.org/10.1021/cr078224o

Kitson S.L., Curr. Pharm. Des. 2007, 13, 2621 DOI: https://doi.org/10.2174/138161207781663000

Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., Miyano M., Science. 2000, 289, 739 DOI: https://doi.org/10.1126/science.289.5480.739

Nowak M., Kołaczkowski M., Pawłowski M., Bojarski A.J,, J. Med. Chem., 2006, 49, 205 DOI: https://doi.org/10.1021/jm050826h

Bronowska A., Leś A., Chilmonczyk Z., Filipek S., Edvardsen Ø., Østensen R., Bioorg. Med. Chem. 2001, 9, 881 DOI: https://doi.org/10.1016/S0968-0896(00)00307-2

Strzelczyk A.A., Jarończyk M., Chilmonczyk Z., Mazurek A.P., Chojnacka-Wójcik E., Sylte I., Biochem. Pharmacol. 2004, 67, 2219 DOI: https://doi.org/10.1016/j.bcp.2004.02.026

Sylte I., Bronowska A., Dahl S.G., Europ. J. Pharm., 2001, 416, 33 DOI: https://doi.org/10.1016/S0014-2999(01)00860-3

López-Rodríguez M.L., Morcillo M.J., Fernández E., Benhamú B., Tejada I., Ayala D., Viso A., Campillo M., Pardo L., Delgado M., Manzanares J., Fuentes J.A., J. Med. Chem. 2005, 48, 2548 DOI: https://doi.org/10.1021/jm048999e

López-Rodríguez M.L., Morcillo M.J., Fernández E., Rosado M.L., Pardo L., Schaper K., J. Med. Chem. 2001, 44, 198 DOI: https://doi.org/10.1021/jm000930t

López-Rodríguez M.L., Vicente B., Deupi X., Barrondo S., Olivella M., Morcillo M.J., Behamú B., Ballesteros J.A., Sallés J., Pardo L., Mol. Pharmacol. 2002, 62, 15 DOI: https://doi.org/10.1124/mol.62.1.15

López-Rodríguez M.L., Morcillo M.J., Fernández E., Benhamú B., Tejada I., Ayala D., Viso A., Olivella M., Pardo L., Delgado M., Manzanares J., Fuentes J.A., Bioorg. Med. Chem. Lett. 2003, 13, 1429

Seeber M., De Benedetti P.G., Fanelli F., J. Chem. Inf.Comput.Sci., 2003, 43, 1520 DOI: https://doi.org/10.1021/ci034069c

Zlatović M., Sukalovic V.V., Schneider Ch., Roglic G.M., Bioorg. Med. Chem. 2006, 14, 2994 DOI: https://doi.org/10.1016/j.bmc.2005.12.023

Becker O.M., Dhanoa D.S., Marantz Y., Chen D., Shacham S., Cheruku S., Heifetz A., Mohanty P., Fichman M., Sharadendu A., Nudelman R., Kauffman M., Noiman S., J. Med. Chem. 2006, 49, 3116 DOI: https://doi.org/10.1021/jm0508641

Zlatović M.V., Šukalivić V.V., Kostić-Rajačić S., Andić D.B, Roglić GM, J. Serb. Chem. Soc., 2006, 71, 1125

Brea J., Rodrigo J., Carrieri A., Sanz F., Cadavid M.I., Enguix M.J., Villazón M., Mengod G., Yolanda Caro, Masaguer Ch.F., Raviña E., Centeno N.B., Carotti A., Loza M.I., J. Med. Chem. 2002, 45, 54 DOI: https://doi.org/10.1021/jm011014y

Roth B.L., Choudhary M.S., Khan N., Uluer A.Z., J. Pharmacol. Exp. Ther. 1997, 280, 576

Shapiro D.A., Kristiansen K., Kroeze W.K., Roth B.L., Mol. Pharmacol, 2000, 58, 877 DOI: https://doi.org/10.1124/mol.58.5.877

Ebersole B.J., Visiers I., Weinstein H., Sealfon S.C., Mol. Pharmacol. 2003, 63, 36 DOI: https://doi.org/10.1124/mol.63.1.36

Klabunde T., Evers A., Chembiochem. 2005, 6, 876 DOI: https://doi.org/10.1002/cbic.200400369

Rowley M., Bristow L. J., Hutson P. H., J. Med. Chem. 2001, 44, 477 DOI: https://doi.org/10.1021/jm0002432

Mahe C., Bernhard M., Bobirnac I., Keser C., Loetscher E., Feuerbach D., Dev K.K., Schoeffter P., Br. J. Pharmacol. 2004, 143, 404 DOI: https://doi.org/10.1038/sj.bjp.0705936

Leopoldo M., Curr. Med. Chem. 2004, 11, 629 DOI: https://doi.org/10.1191/0969733004ne746xx

Hoyer D., Hannon J.P., Martin G.R., Pharm. Biochem. Behav. 2002, 71, 533 DOI: https://doi.org/10.1016/S0091-3057(01)00746-8

Kołaczkowski M., Nowak M., Pawłowski M., Bojarski A.J. – J. Med. Chem. 2006, 49, 6732 DOI: https://doi.org/10.1021/jm060300c

Lopez-Rodriguez M. L., Porras E., Morcillo M. J., Benhamu B., Soto L. J., Lavandera J. L., Ramos J. A., Olivella M., Campillo M., Pardo L., J. Med. Chem. 2003, 46, 5638 DOI: https://doi.org/10.1021/jm030841r

Vermeulen E. S., Schmidt A. W., Sprouse J. S., Wikstrom H. V., Grol C. J., J. Med. Chem. 2003, 46, 5365 DOI: https://doi.org/10.1021/jm030826m

Anna Bielenica

Affiliation:

Katedra i Zakład Chemii Medycznej, I Wydział Lekarski Warszawski Uniwersytet Medyczny, Poland

Jerzy Kossakowski

Affiliation:

Katedra i Zakład Chemii Medycznej, I Wydział Lekarski Warszawski Uniwersytet Medyczny, Poland

BINDING MODES OF LONG-CHAIN ARYLPIPERAZINES TO 5-HT1A, 5-HT2A AND 5-HT7 RECEPTORS

Anna Bielenica

Jerzy Kossakowski

Abstract

Keywords:

Most read articles by the same author(s)

Similar Articles

Anna Bielenica

Jerzy Kossakowski